RNA interference agent plozasiran targets APOC3 for effective mixed hyperlipidemia treatment
In a recent study published in The New England Journal of Medicine, researchers evaluate the efficacy of plazosiran treatment on fasting triglyceride levels in adult patients with mixed hyperlipidemia (MH). Study: Plozasiran, an RNA interference agent …